Atlas Trials

Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Trigeminal Neuralgia. Safety Issues.

Clinical trial NCT02662972 · COMPLETED

Trial details

NCT number
NCT02662972
Sponsor
Norwegian University of Science and Technology
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Trigeminal NeuralgiaHeadache Disorders
Start date
2016-05-01
Primary completion
2018-11-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.